Skip to main content

Don’t invest unless you’re prepared to lose all your money.
These are high-risk investments and you are unlikely to be protected if something goes wrong.
Take 2 mins to learn more.


Keep up to date with what is going on at Deepbridge, our investee companies and other exciting news.

Important Notice: Investments in unquoted companies carries high risks and investors could lose all funds invested. Investors should not invest if capital is required in the near term. No established market exists for the trading of shares in private companies, making it difficult to sell shares. The value of tax reliefs depend on personal circumstances and may be subject to change in the future. The availability of tax reliefs depends on the Company invested in maintaining its qualifying status. Past performance is not a guide to the future performance of an investment, and investors are encouraged to take independent legal, tax and financial advice before considering an investment.
Research reveals advisers prefer EIS to VCT

27th April 2023

Deepbridge have recently concluded an adviser survey that suggests financial advisers utilise the Enterprise Investment Scheme (EIS) investment…

Full article
Genome Diagnostics closes £1.4m Funding Round

27th April 2023

GenoME Diagnostics, an investee company within Deepbridge's Life Sciences SEIS portfolio has recently closed a £1.4 million funding round which will…

Full article
Enso Tyres
Successful results from Enso Tyres

27th April 2023

ENSO Tyres Limited, one of Deepbridge's Technology Growth EIS Companies, has "successfully proven" the benefits of its specially developed electric…

Full article
Andrew A
Andrew Aldridge Appointed to EISA Board

3rd March 2023

The Enterprise Investment Scheme Association (EISA) has appointed Andrew Aldridge (Partner & Chief Marketing Officer at Deepbridge Capital) to…

Full article
EIS Tax year End Opportunities
Tax year End - EIS Opportunities

2nd February 2023

As we rapidly approach tax year end and clients submit their self-assessment tax returns, financial adviser’s attention will be drawn to tax planning…

Full article
IHT Receipits Hit £5.3 Billion

1st February 2023

HM Revenue and Customs (HMRC) recorded a £700 Million uptick in Inheritance Tax (IHT) receipts between April and December last year, totalling £5.3…

Full article
Deepbridge Appoints New Senior Investment Director

20th January 2023

Deepbridge are pleased to announce the appointment of Dr Andy Round, as Senior Investment Director, within the Deepbridge Life Sciences EIS team. …

Full article
Deepbridge Review 2022
Deepbridge Review 2022

11th January 2023

  Image Throughout 2022, the Deepbridge team and I were heavily focused on…

Full article
2023 trends
MedTech Trends in 2023

5th January 2023

Bernard Ross, CEO and Founder of Sky Medical Technology Ltd. has recently been featured in a Med-Tech News article regarding what he expects from the…

Full article
Microplate DX
Microplate DX Secures £500k Funding

12th December 2022

Award-winning University of Strathclye spinout company, Microplate Dx Limited has recently secured significant seed funding to scale-up development…

Full article
Liverpool ChiroChem Ltd
Liverpool Chirochem Secures £2.2m Investment

5th December 2022

Liverpool ChiroChem Ltd. (LCC), an investee company within Deepbridge Capital's Life Science EIS fund, has recently raised £2.2 million of investment…

Full article
Top 5 Considerations for IFAs

5th December 2022

Andrew Aldridge, Partner & Chief Marketing Officer at Deepbridge Capital, was recently featured in an article in IFA Magazine regarding his top 5…

Full article